Data as of Dec 06
| +0.19 / +4.70%|
The 5 analysts offering 12-month price forecasts for Novavax Inc have a median target of 4.00, with a high estimate of 11.00 and a low estimate of 4.00. The median estimate represents a -5.44% decrease from the last price of 4.23.
The current consensus among 5 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.